Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
No clinical trial has tested all three together
The latter is currently considered the most effective incretin-based agent for lowering body weight [12]
2030 estimates range from $95B (Goldman Sachs) to $268B (BCC Research) For a detailed breakdown of Eli Lilly's Q1 2026 earnings, including segment-level performance and management commentary on the GLP-1 franchise trajectory, the full episode is available at betafinch.com/podcasts/lly.
Or three 10mg vials (weeks 1-8) plus three 30mg vials (weeks 9-16)
US$ 27.49
US$ 26.11
US$ 24.61
